Mediware and Cytolon will work together to improve the ease of
hematopoietic stem cell matching in cord blood banking
Umbilical cord blood hematopoietic stem cells are most often transplanted to patients with certain blood or bone marrowcancers, such as multiple myeloma or leukemia. The best human leukocyte antigen (HLA) match must be selected for transplants to reduce the risk of graft-versus-host disease and other complications of allogeneic hematopoietic stem cells transplantation.
Cytolon AG’s Internet-based platform, CordMatch® matches cord blood units globally to allow for secure and cost-free communication between clinicians and coordinators with the UCB product providers. This innovative platform enables immediate and comprehensive search on all registered UCB data according to the clinician’s protocol and provides comprehensive information reports on relevant stem cell products in real-time for informed decision making. CordMatch is a patented Class 1 medical device registered in both
This new collaboration will bring substantially greater connectivity to the cord blood banks already using Mediware's existing cord blood banking software. The collaboration will expand Cytolon's customer base and increase the number of cord blood units listed for transplant.
The Transtem™ software system from Mediware provides complete process management from online donor registration and account creation, through product collection, manufacturing, storage, testing, label generation and release – all within a single Web-based system. Together, CordMatch and Transtem will provide an enhanced user experience for listing, searching and selecting cord blood products for transplant while increasing process efficiency and safety.
“We see great opportunities for our customers by working together with Mediware,” said
Mediware delivers interoperable best-of-breed software systems that improve efficiencies and address safety concerns, enabling healthcare organizations to improve care processes while decreasing costs. Core Mediware solutions include blood management technologies for hospitals and blood centers; cell therapy solutions for cord blood banks, blood and marrow transplant centers, cellular therapy laboratories and regenerative medicine programs; medication management solutions for hospitals, behavioral health facilities, infusion and specialty pharmacy providers; business intelligence-based performance management solutions for clinical, regulatory and financial aspects of the broader healthcare market; and rehabilitation therapy and respiratory care solutions. For more information about Mediware products and services, visit our website at www.mediware.com.
CordMatch is a high performance, Internet-based platform that matches cord blood units to the patients who need them. CordMatch® is unique as it integrates product search, matching, selection, logistics and follow up steps in a single platform.
Most Popular Stories
- 3 Shot Dead in Venezuela Unrest
- Chinese May Have Spotted Malaysia Airlines Debris
- Several Texas Cities Top Job Search List
- Why Buffett Bets Big on Green Energy
- Wall Street Rally Heads Off 3rd Day of Decline
- Senate Committee OKs Bill to Sanction Russia
- Better Pay Means Bigger Profits: Strategist
- G7 Presses Russia to Pull Troops Out of Crimea
- Obama's 'Between Two Ferns' Appearance Has Conservatives Upset
- Jan Brewer Out on Term Limits